These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 770243)

  • 1. [Final results in the management of the climacteric with a combination of estradiol and estrone sulfate].
    Ruiz Moreno JA; Rubio Lotvin B; Bolio Arista R; de Larios NM
    Ginecol Obstet Mex; 1976 Feb; 39(232):145-9. PubMed ID: 770243
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of the climacteric syndrome with a combination of estrone sulfate and estradiol. Preliminary report].
    Ruiz Moreno JA; Rubio Lotvin B; De Larios NM; Bolio Arista R
    Ginecol Obstet Mex; 1973 Sep; 34(203):273-9. PubMed ID: 4756182
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural and synthetic oestrogens in the female climacteric.
    Practitioner; 1977 Apr; 218(1306):573-9. PubMed ID: 323841
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new synthetic estrone derivative for the treatment of climacteric disorders].
    Cyran W
    Med Welt; 1979 Mar; 30(10):384-8. PubMed ID: 368495
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with estrogen treatment of the climacteric syndrome (author's transl)].
    Dahinden UA; Hauser GA
    Ther Umsch; 1974 Mar; 31(3):188-96. PubMed ID: 4816758
    [No Abstract]   [Full Text] [Related]  

  • 6. [Climacteric syndrome : clinical experiences using promestriene].
    Campana G; Di Grancesco
    Ann Ostet Ginecol Med Perinat; 1976; 97(3):189-97. PubMed ID: 797296
    [No Abstract]   [Full Text] [Related]  

  • 7. Endocrine and metabolic effects of low-dose estrogen-progestin treatment in climacteric women.
    Ylöstalo P; Kauppila A; Kivinen S; Tuimala R; Vihko R
    Obstet Gynecol; 1983 Dec; 62(6):682-6. PubMed ID: 6355937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS; Kang BM; Yoon BK; Choi H; Park HM; Kim JG
    Maturitas; 2007 Aug; 57(4):361-9. PubMed ID: 17467203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transdermal and oral hormone substitution with estrogens: a comparison].
    Schindler AE
    Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
    Rachev E; Katsarova M; Bŭrdarova I
    Akush Ginekol (Sofiia); 1991; 30(2):73-6. PubMed ID: 1883055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
    Grisar J; Travica S; Metka M; Pietschmann P
    Wien Klin Wochenschr; 1999 Dec; 111(24):1035-43. PubMed ID: 10677891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cyclic treatment of climacteric disorders with genuine estrogens].
    Bartl W; Kemeter P; Friedrich F; Seidl A
    Gynakol Rundsch; 1982; 22(1):23-48. PubMed ID: 7076044
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of genuine estrogens as substitution therapy in the climacteric on blood pressure and the renin-angiotensin system in normotensive and hypertensive women].
    Arnung K; Jespersen C; Hilden T; Nielsen F; Nielsen MD; Giese J; Hagen C
    Ugeskr Laeger; 1982 Dec; 144(49):3666-9. PubMed ID: 7170758
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of the climacteric syndrome. Controlled study of a combination of low-dose clonidine and low-dose conjugated estrogens].
    Schindler AE; Heners D; Pater T; Wendel U; Donath EM
    Fortschr Med; 1984 Dec; 102(47-48):1213-6. PubMed ID: 6097521
    [No Abstract]   [Full Text] [Related]  

  • 15. [1st research on the treatment of climacteric with a new drug (controlled clinical study)].
    Cazzola D; Confalonieri A; Lucchese V
    Minerva Ginecol; 1974 Mar; 24(5):250-64. PubMed ID: 4603971
    [No Abstract]   [Full Text] [Related]  

  • 16. [The neurovegatative reaction-situation in climacteric. Modification of blood pressure regulation by estrogens].
    Carol W; Krepler S; Hempel E; Klinger G
    Zentralbl Gynakol; 1976; 98(9):546-53. PubMed ID: 936820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitution.
    Luotola H
    Ann Clin Res; 1983; 15 Suppl 38():1-121. PubMed ID: 6367617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of hormone replacement therapy with buspirone in the treatment of climacteric complaints].
    Szántó F
    Orv Hetil; 2000 Apr; 141(16):835-7. PubMed ID: 10817010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen replacement therapy and hypertension.
    Mashchak CA; Lobo RA
    J Reprod Med; 1985 Oct; 30(10 Suppl):805-10. PubMed ID: 3908670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gynecological, hematological and metabolic studies during therapy with an estrogen-gestagen combination preparation].
    Schneider WH; Matt K; Irsigler K; Lageder H; Schubert H
    Arzneimittelforschung; 1975 Jun; 25(6):959-62. PubMed ID: 1100056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.